You just read:

Valeant Pharmaceuticals International, Inc. Agrees to Acquire Obagi Medical Products, Inc. for $19.75 Per Share in Cash

News provided by

Valeant Pharmaceuticals International, Inc.

Mar 20, 2013, 08:00 ET